International – Page 5 – Policy & Medicine

Eight Months After The GDPR: Where Do We Stand?

IFPMA New Code of Practice Embraced by Biopharmaceutical R&D Industry

IFPMA Ethics Code Revised, Aligns with PhRMA Code, Bans Entertainment and Promotional Aids

AMA Adopts Policy Supporting Importation of Prescription Drugs from Canada

Physician in Ontario? Your Annual Income Could Be Public Information.

Biosimilars Rapidly Gain Market Share in EU

Is British Columbia Set to Follow Ontario in Canadian Pharmaceutical Transparency?

Health Canada Takes on Opioid Transparency – Notice of Intent to Restrict Marketing and Advertising of Opioids

Preparing for the 2018 Ethical MedTech, APACMed, and China Codes

Privacy Upheaval – Exploring the Impact of the GDPR on Companies Sponsoring and Managing Global Clinical Research